US3645692A - Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses - Google Patents

Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses Download PDF

Info

Publication number
US3645692A
US3645692A US832432A US3645692DA US3645692A US 3645692 A US3645692 A US 3645692A US 832432 A US832432 A US 832432A US 3645692D A US3645692D A US 3645692DA US 3645692 A US3645692 A US 3645692A
Authority
US
United States
Prior art keywords
blood
absorbent carrier
process according
determination
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US832432A
Other languages
English (en)
Inventor
Harald Stork
Felix Helmut Schmidt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19691913817 external-priority patent/DE1913817C3/de
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of US3645692A publication Critical patent/US3645692A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525Stabilizing or preserving

Definitions

  • the present invention relates to a process for the preparation, preservation and transportation of blood and serum samples for use thereof in the determination of chemical and biochemical components contained therein. More particularly the invention relates to a process for the preparation, preservation and transportation of blood and serum samples for use in the determination of chemical and biochemical components contained therein such as sugars, i.e., glucose and galactose, lipids, such as triglycerides and cholesterol, etc.
  • the process according to the present invention permits the determination in blood not only of sugars, such as glucose and galactose, but also of lipids, such as triglycerides and cholesterol. Since all of the operations which are necessary for obtaining serum from whole blood are eliminated, the amount of blood necessary for the determinations can be reduced from 0.5 ml. to 0.05 ml. This is particularly important for large scale investigations as the small amount of blood needed can be drawn as capillary blood, vena-puncture no longer being necessary.
  • a further advantage of the process according to the invention is that several blood samples can be taken from the same small laboratory animal in serial tests without causing any harm to the animal. This, of course, results in that the degree of accuracy of the results obtained is considerably increased.
  • the prepared and dried samples obtained by the process according to the present invention can simply be transported and stored in an envelope and, yet, can be used for the carrying out of quantitative determinations with a great degree of accuracy, even following the lapse of considerable time after the taking of the blood samples.
  • ion exchange paper As absorbent carriers having ion exchange properties, it is preferred to use ion exchange papers.
  • ion exchange paper there can be used, depending upon the nature of the blood or serum components which are to be determined, not only cation exchangers but also anion exchangers.
  • Glucose and galactose are preferably stabilized, i.e., preserved in the weakly acidic range, too low pH values having to be avoided in connection with carrying out glucose determination since otherwise glucose is split off from the cellulose forming part of the paper which would then inaccurately result in glucose values which are too high.
  • anion exchange papers Since triglycerides are, in the course of enzymatic investigations, subjected to alkaline saponification, anion exchange papers have proved to be particularly well suited for the preparation and stabilization, i.e., preservation of samples intended for this purpose. Furthermore, samples intended for cholesterol determinations are also best stabilized on weakly basic ion exchange papers.
  • absorbent carriers such as for instance compressed cellulose, hydrophilic synthetic resins, textile fabrics, wicks or layers of organic or inorganic powders or granulates having ion exchange properties fixed to suitable substrates by means of adhesives, such as by the addition of glue, it being immaterial whether the ion exchange properties depend upon the molecular structure of the absorbent carrier or are imparted to the carrier by a subsequent impregnation with suitable materials.
  • galactose takes place, after elution of the absorbent carrier, utilizing enzyme galactose dehydrogenase, and using Warburg's optical test at 366 nm.
  • the determination of cholesterol is carried out, after elution of the absorbent carrier with a suitable organic solvent, preferably with a mixture of chloroform and methanol (2:1), using for the determination the analytical method described by Watson (D. Clin. Chim. Acta, 5, 637/ I960).
  • EXAMPLE 1 Serial determination of the blood glucose content in rabbits (with additional glucose loading).
  • Whatman cation exchanger paper WA 2 (AMBERLITE IR-C 50) was cut up into squares having 3 cm. edges.
  • the prepared pieces of paper were eluted by the method described in Example I, and thereafter the eluate was also analyzed using the Warburgs optical test.
  • the mentioned ion-exchange papers named Whatman Amberlitev JRC 50 and JRA 400 are cellulose filter papers containing poly-methacrylic acid resins and polystyrene resins with quarternary ammonio groups. They are manufactured by Whatman and Balstone Ltd. Maidstone, England.
  • Process for the preparation, preservation and transportation of blood and serum samples for use in the analytical determination of chemical and biochemical components contained therein which comprises applying onto an absorbent carrier having ion exchange properties a sample of serum or blood and drying the absorbent carrier and sample.
  • said absorbent carrier is a member selected from the group consisting of paper, compressed cellulose, textile fabrics and hydrophilic synthetic resins.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
US832432A 1968-07-15 1969-06-11 Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses Expired - Lifetime US3645692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1773841 1968-07-15
DE19691913817 DE1913817C3 (de) 1969-03-19 Verwendung eines Verfahrens zur Vorbereitung, Konservierung und zum Transport von Blut- und Serumproben

Publications (1)

Publication Number Publication Date
US3645692A true US3645692A (en) 1972-02-29

Family

ID=25755644

Family Applications (1)

Application Number Title Priority Date Filing Date
US832432A Expired - Lifetime US3645692A (en) 1968-07-15 1969-06-11 Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses

Country Status (6)

Country Link
US (1) US3645692A (xx)
BR (1) BR6910695D0 (xx)
CA (1) CA928198A (xx)
ES (1) ES369558A1 (xx)
GB (1) GB1235577A (xx)
SE (1) SE352963B (xx)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825410A (en) * 1970-05-13 1974-07-23 K Bagshawe Performance of routine chemical reactions in compartmentalized containers
US4159193A (en) * 1976-04-29 1979-06-26 I.N.R.S., Institut National de Recherche et de Securite pour la Prevention des Accidents du travail et des Maladies Professionnelles Method for sampling and fixing urinary metabolites on an immobilizing support and apparatus therefor
EP0035726A1 (de) * 1980-03-08 1981-09-16 Roche Diagnostics GmbH Verfahren und diagnostisches Mittel zur direkten Bestimmung des Lipidgehaltes der beta-Lipoproteine des Blutes
EP0583078A2 (en) * 1992-07-14 1994-02-16 Wallac Oy Method and apparatus for handling samples
US20040059285A1 (en) * 2002-07-04 2004-03-25 Inovio As Electroporation device and injection apparatus
US20050070841A1 (en) * 2002-07-04 2005-03-31 Inovio As Electroporation device and injection apparatus
WO2012118428A1 (en) * 2011-02-28 2012-09-07 Ge Healthcare Uk Limited Sample preservation method and sample application substrate
WO2013066249A1 (en) * 2011-10-31 2013-05-10 Ge Healthcare Bio-Sciences Ab Sample preservation method and sample preservation substrate
US10638963B2 (en) 2017-01-10 2020-05-05 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
US11266337B2 (en) 2015-09-09 2022-03-08 Drawbridge Health, Inc. Systems, methods, and devices for sample collection, stabilization and preservation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3380888A (en) * 1961-03-31 1968-04-30 Squibb & Sons Inc Test units
US3494744A (en) * 1967-10-26 1970-02-10 Bio Rad Laboratories Method for determination of proteinbound iodinated components

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3380888A (en) * 1961-03-31 1968-04-30 Squibb & Sons Inc Test units
US3494744A (en) * 1967-10-26 1970-02-10 Bio Rad Laboratories Method for determination of proteinbound iodinated components

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Pileggi, V. J., J. Clin. Endocr. & Meta., Vol. 21, pp. 1272 1279 (1961) *

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3825410A (en) * 1970-05-13 1974-07-23 K Bagshawe Performance of routine chemical reactions in compartmentalized containers
US4159193A (en) * 1976-04-29 1979-06-26 I.N.R.S., Institut National de Recherche et de Securite pour la Prevention des Accidents du travail et des Maladies Professionnelles Method for sampling and fixing urinary metabolites on an immobilizing support and apparatus therefor
EP0035726A1 (de) * 1980-03-08 1981-09-16 Roche Diagnostics GmbH Verfahren und diagnostisches Mittel zur direkten Bestimmung des Lipidgehaltes der beta-Lipoproteine des Blutes
EP0583078A2 (en) * 1992-07-14 1994-02-16 Wallac Oy Method and apparatus for handling samples
EP0583078A3 (en) * 1992-07-14 1994-11-17 Wallac Oy Sample handling apparatus and method and sample collection system.
US20050070841A1 (en) * 2002-07-04 2005-03-31 Inovio As Electroporation device and injection apparatus
US10376692B2 (en) 2002-07-04 2019-08-13 Inovio As Electroporation device and injection apparatus
US7328064B2 (en) 2002-07-04 2008-02-05 Inovio As Electroporation device and injection apparatus
US20080234655A1 (en) * 2002-07-04 2008-09-25 Inovio As Electroporation device and injection apparatus
US20040059285A1 (en) * 2002-07-04 2004-03-25 Inovio As Electroporation device and injection apparatus
US11471675B2 (en) 2002-07-04 2022-10-18 Inovio Pharmaceuticals, Inc. Electroporation device and injection apparatus
WO2012118428A1 (en) * 2011-02-28 2012-09-07 Ge Healthcare Uk Limited Sample preservation method and sample application substrate
US9989446B2 (en) 2011-02-28 2018-06-05 Ge Healthcare Uk Limited Sample preservation method and sample application substrate
WO2013066249A1 (en) * 2011-10-31 2013-05-10 Ge Healthcare Bio-Sciences Ab Sample preservation method and sample preservation substrate
US10371608B2 (en) 2011-10-31 2019-08-06 Ge Healthcare Bio-Sciences Ab Sample preservation method and sample preservation substrate
US11266337B2 (en) 2015-09-09 2022-03-08 Drawbridge Health, Inc. Systems, methods, and devices for sample collection, stabilization and preservation
US10638963B2 (en) 2017-01-10 2020-05-05 Drawbridge Health, Inc. Devices, systems, and methods for sample collection
US10888259B2 (en) 2017-01-10 2021-01-12 Drawbridge Health, Inc. Cartridge assemblies for storing biological samples
US10932710B2 (en) 2017-01-10 2021-03-02 Drawbridge Health, Inc. Carriers for storage and transport of biological samples
US11298060B2 (en) 2017-01-10 2022-04-12 Drawbridge Health, Inc. Devices for collecting biological samples

Also Published As

Publication number Publication date
CA928198A (en) 1973-06-12
DE1913817B2 (de) 1977-01-20
DE1913817A1 (de) 1970-10-01
BR6910695D0 (pt) 1973-05-08
ES369558A1 (es) 1971-06-01
GB1235577A (en) 1971-06-16
SE352963B (xx) 1973-01-15

Similar Documents

Publication Publication Date Title
MURPHY ‘Sephadex’column chromatography as an adjunct to competitive protein binding assays of steroids
Turková Affinity chromatography
Rimerman et al. Phosphate-induced protein chromatography
Villafranca et al. Heptulose synthesis from nonphosphorylated aldoses and ketoses by spinach transketolase
US3645692A (en) Process for the preparation, preservation and transportation of blood and serum samples for use in clinical analyses
EP0235526A2 (de) Aktivierte Polymerfestkörper und Verfahren zu ihrer Herstellung
Johnson et al. Inactivation of tetrameric rabbit muscle pyruvate kinase by specific binding of 2 to 4 moles of pyridoxal 5'-phosphate
GB1573512A (en) Method of selectively removing lipoprotein from blood plasma or serum
DE3715485A1 (de) Stabilisierung von ss-galactosidase
Mackenzie et al. Differences between Liver and Hepatoma Cells in Their Complements of Adenosine 3′: 5′-Monophosphatebinding Proteins and Protein Kinases
EP0032204B1 (de) Verfahren und Mittel zur immunologischen Bestimmung von Enzymen
US4188189A (en) Quantitative testing for vitamin B12
Smith et al. Hepatotoxic action of chromatographically separated fractions of Aspergillus flavus extracts
Brostrom et al. Choline kinase from brewers' yeast: Partial purification, properties, and kinetic mechanism
US3623841A (en) Separation by thin-layer chromatography with a two-layer plate
Woodin The effect of staphylococcal leucocidin on the leucocyte
Narasimhachari et al. Indolethylamine-N-methyltransferase in serum samples of schizophrenics and normal controls
Goodman et al. A competitive binding protein assay for juvenile hormone
Lin et al. Chemical composition of Azotobacter vinelandii cysts
Gorringe et al. Organization of the glycolytic enzymes in Escherichia coli
Kim Folate and polyamine content of undifferentiated and differentiated wheat stem rust uredosporelings
Dijong et al. Gas chromatographic determination of gangliosides in mouse cell lines and in virally transformed derivative lines
Beeckmans et al. Immobilized enzymes as tools for the demonstration of metabolon formation. A short overview
EP1042671B1 (de) Nachweis von adenosin in kleinen proben
US3657118A (en) Process for the determination of catecholamine and serotonin metabolites